Cargando…
A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
BACKGROUND: Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the P...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416929/ https://www.ncbi.nlm.nih.gov/pubmed/30871561 http://dx.doi.org/10.1186/s12913-019-3995-3 |
_version_ | 1783403457890222080 |
---|---|
author | Vasilevskis, Eduard E. Shah, Avantika S. Hollingsworth, Emily K. Shotwell, Matthew S. Mixon, Amanda S. Bell, Susan P. Kripalani, Sunil Schnelle, John F. Simmons, Sandra F. |
author_facet | Vasilevskis, Eduard E. Shah, Avantika S. Hollingsworth, Emily K. Shotwell, Matthew S. Mixon, Amanda S. Bell, Susan P. Kripalani, Sunil Schnelle, John F. Simmons, Sandra F. |
author_sort | Vasilevskis, Eduard E. |
collection | PubMed |
description | BACKGROUND: Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the PAC setting reduces the total number of medications among older patients. METHODS: The Shed-MEDS study is a 5-year, randomized controlled clinical intervention trial comparing a patient-centered describing intervention with usual care among older (≥50 years) hospitalized patients discharged to PAC, either a skilled nursing facility (SNF) or an inpatient rehabilitation facility (IPR). Patient measurements occur at hospital enrollment, hospital discharge, within 7 days of PAC discharge, and at 60 and 90 days following PAC discharge. Patients are randomized in a permuted block fashion, with block sizes of two to four. The overall effectiveness of the intervention will be evaluated using total medication count as the primary outcome measure. We estimate that 576 patients will enroll in the study. Following attrition due to death or loss to follow-up, 420 patients will contribute measurements at 90 days, which provides 90% power to detect a 30% versus 25% reduction in total medications with an alpha error of 0.05. Secondary outcomes include the number of medications associated with geriatric syndromes, drug burden index, medication adherence, the prevalence and severity of geriatric syndromes and functional health status. DISCUSSION: The Shed-MEDS trial aims to test the hypothesis that a patient-centered deprescribing intervention initiated in the hospital and continuing through the PAC stay will reduce the total number of medications 90 days following PAC discharge and result in improvements in geriatric syndromes and functional health status. The results of this trial will quantify the health outcomes associated with reducing medications for hospitalized older adults with polypharmacy who are discharged to post-acute care facilities. TRIAL REGISTRATION: This trial was prospectively registered at clinicaltrials.gov (NCT02979353). The trial was first registered on 12/1/2016, with an update on 09/28/17 and 10/12/2018. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-3995-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6416929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64169292019-03-25 A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial Vasilevskis, Eduard E. Shah, Avantika S. Hollingsworth, Emily K. Shotwell, Matthew S. Mixon, Amanda S. Bell, Susan P. Kripalani, Sunil Schnelle, John F. Simmons, Sandra F. BMC Health Serv Res Study Protocol BACKGROUND: Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the PAC setting reduces the total number of medications among older patients. METHODS: The Shed-MEDS study is a 5-year, randomized controlled clinical intervention trial comparing a patient-centered describing intervention with usual care among older (≥50 years) hospitalized patients discharged to PAC, either a skilled nursing facility (SNF) or an inpatient rehabilitation facility (IPR). Patient measurements occur at hospital enrollment, hospital discharge, within 7 days of PAC discharge, and at 60 and 90 days following PAC discharge. Patients are randomized in a permuted block fashion, with block sizes of two to four. The overall effectiveness of the intervention will be evaluated using total medication count as the primary outcome measure. We estimate that 576 patients will enroll in the study. Following attrition due to death or loss to follow-up, 420 patients will contribute measurements at 90 days, which provides 90% power to detect a 30% versus 25% reduction in total medications with an alpha error of 0.05. Secondary outcomes include the number of medications associated with geriatric syndromes, drug burden index, medication adherence, the prevalence and severity of geriatric syndromes and functional health status. DISCUSSION: The Shed-MEDS trial aims to test the hypothesis that a patient-centered deprescribing intervention initiated in the hospital and continuing through the PAC stay will reduce the total number of medications 90 days following PAC discharge and result in improvements in geriatric syndromes and functional health status. The results of this trial will quantify the health outcomes associated with reducing medications for hospitalized older adults with polypharmacy who are discharged to post-acute care facilities. TRIAL REGISTRATION: This trial was prospectively registered at clinicaltrials.gov (NCT02979353). The trial was first registered on 12/1/2016, with an update on 09/28/17 and 10/12/2018. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-3995-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-14 /pmc/articles/PMC6416929/ /pubmed/30871561 http://dx.doi.org/10.1186/s12913-019-3995-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Vasilevskis, Eduard E. Shah, Avantika S. Hollingsworth, Emily K. Shotwell, Matthew S. Mixon, Amanda S. Bell, Susan P. Kripalani, Sunil Schnelle, John F. Simmons, Sandra F. A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial |
title | A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial |
title_full | A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial |
title_fullStr | A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial |
title_full_unstemmed | A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial |
title_short | A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial |
title_sort | patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the shed-meds randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416929/ https://www.ncbi.nlm.nih.gov/pubmed/30871561 http://dx.doi.org/10.1186/s12913-019-3995-3 |
work_keys_str_mv | AT vasilevskiseduarde apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT shahavantikas apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT hollingsworthemilyk apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT shotwellmatthews apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT mixonamandas apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT bellsusanp apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT kripalanisunil apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT schnellejohnf apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT simmonssandraf apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT apatientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT vasilevskiseduarde patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT shahavantikas patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT hollingsworthemilyk patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT shotwellmatthews patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT mixonamandas patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT bellsusanp patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT kripalanisunil patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT schnellejohnf patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT simmonssandraf patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial AT patientcentereddeprescribinginterventionforhospitalizedolderpatientswithpolypharmacyrationaleanddesignoftheshedmedsrandomizedcontrolledtrial |